Dr. Richard Katz Featured in Several Scientific Journals for Research on Geriatric Depression, Neuroscience, and Aging

Danbury, Connecticut, 26th April 2023, ZEX PR WIREDr. Richard Katz has been a part of many important publications in high impact medical journals. Among the many studies Dr. Katz has been involved, includes differing effects of a placebo response as opposed to an antidepressant response, event-related potentials in an emotional go/no-go task and remission of geriatric depression, enhanced and bi-lateralized visual sensory processing in the ventral stream as a feature of normal aging, as well as cognitive control in late-life depression and response inhibition deficits and dysfunction of the anterior cingulate cortex.

In The American Journal of Geriatric Psychiatry, Dr. Richard Katz and colleagues published the following conclusions : “While structural neuroimaging studies have consistently pointed to dysfunction in the Anterior Cingulate Cortex (ACC) as an important neural substrate in geriatric depression, electrophysiological studies of ACC function have been considerably less consistent in their findings. Here, using a well-characterized and highly challenging task-switching paradigm, we assessed response inhibition mechanisms in the ACC as reflected by the N2 ERP component and the N2-effect. Our data suggest clear differences between non-depressed elderly participants and those suffering from late-life depression, non-depressed participants showed a robust N2-effect whereas this effect was absent in the depressed cohort. These data suggest functional deficits in the ACC during response inhibition processes and suggest that these deficits in depressed subjects may only become apparent under high-load conditions when this system is particularly taxed.” (Am J Geriatr Psychiatry. 2010 Nov; 18(11): 1017–1025.)

Findings by Dr. Katz and colleagues were featured in the journal Neurobiology of Aging, which publishes the results of studies in behavior, biochemistry, cell biology, endocrinology, molecular biology, morphology, neurology, neuropathology, pharmacology, physiology and protein chemistry in which the primary emphasis involves mechanisms of nervous system changes with age or diseases associated with age. In the article they examined the hypothesis that “enhanced and bilateralized visual sensory processing in the ventral stream may be a feature of normal aging.” Their conclusions, in part, stated: “An enhancement in amplitude in elderly participants during the N1 component of the VEP (168 ms) is indicative of age-related differences in early sensory processing. We found age-related changes in scalp topography and underlying sources of N1 in the form of reduced hemispheric asymmetry for early sensory processing.” The study in its entirety is provided here.

The results of studies examining event-related potentials in an emotional go/no-go task and remission of geriatric depression were published in NeuroReport, in which Dr. Richard Katz and colleagues concluded that their “findings suggest that two distinct conflict-processing functions of the anterior cingulate are important for antidepressant response of geriatric depression.” (https://journals.lww.com/neuroreport/toc/2007/02120

Investigating the response to an antidepressant and its relation to the placebo response, Dr. Katz and co-authors found that “the placebo response embedded in drug response confounds studies seeking to identify brain mechanisms essential for pharmacologic response. Exclusion of patients who fail to meet entry criteria at the end of a placebo lead-in phase has been inadequate to reduce the effect of placebo during pharmacologic trials.” Their study then focused on the placebo lead-in phase and examined whether change in severity of depression during placebo lead-in predicted change in depressive symptoms during antidepressant treatment. 

Results cited in their abstract in The American Journal of Geriatric Psychiatry stated: “Worsening or limited change in depression during placebo treatment predicted improvement in depressive symptoms during escitalopram treatment. Limited change in anxiety, melancholia, helplessness, and paranoia during placebo treatment were the strongest predictors of improvement in depression while on escitalopram.” This led Dr. Katz and his fellow researchers to conclude: “These findings, if replicated, may be used to characterize depressed older patients likely to respond to the pharmacologic action of antidepressants rather than the placebo response embedded in drug trials and thus improve the methodology of biomarker studies of antidepressant response. On a clinical level, depressed older patients who improve during a prolonged evaluation may be candidates for nonpharmacologic treatments because their drug response may be limited.” 

About Dr. Richard Katz

Richard Katz, MD, MHA is a pharmaceutical executive with extensive experience in central nervous system, regenerative – biological therapies, clinical trial design and operations. Dr. Katz has consulted across many therapeutic areas in the pharmaceutical and life science industries. His focus is on delivering more effective, affordable, treatments to improve patient health outcomes making a global impact on healthcare than what is possible by treating only one patient at a time.

The Post Dr. Richard Katz Featured in Several Scientific Journals for Research on Geriatric Depression, Neuroscience, and Aging first appeared on ZEX PR Wire

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

News

Zoey Exporting Co. Ltd is committed to Delivering High-quality Laser Machinery in China

With a strong emphasis on innovation and customer satisfaction, Zoey Exporting Co. Ltd has established itself as a trusted name in the laser machinery...

Authorized users offer authorized user tradelines to boost credit scores

California, US, 4th August 2022, ZEXPRWIRE, People looking to improve their credit score can now buy authorized user tradelines from authorized users. For a...

Let Southwest Florida R.E Group Help You Make The Right Real Estate Investments In Florida’s Flourishing Real Estate Market

The Southwest Florida Real Estate Group Is Dedicated To Assisting You When You’re Buying Or Selling Real Estate In Florida’s Thriving Market. Bonita Springs, Florida,...

Kratom Products Are Now Available In Colorado

Pueblo, CO, 22nd November 2022, ZEXPRWIRE, Kratom has been fast-moving in the global market, with many people looking for natural alternatives to conventional medications....

BlitsEstates Unveils Blitscoin: A Game-Changer for Real Estate and Crypto Investors

We have provided investors with the unique opportunity to digitally invest in Real Estate around the world via Fiat. Our experienced team selects the...

Nourish the Body and Mind with EnerHealth Botanicals

Longmont, Colorado, 13th March 2023, ZEXPRWIRE, Enerhealth Botanicals is Proud to announce 2 new coffee products to their Organic Mushroom Coffee line “Enerhealth Botanicals is...

Tunisia: A Fascinating Destination for History, Culture, and Adventure

Tunisia, located in North Africa, is a country steeped in history, culture, and natural beauty. Tunis, Tunisia, Tunisia, 4th Mar 2023, King NewsWire – Tunisia,...